Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.65 |
| ▸ | STAT3 | P40763 | 12/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29425898 | 1.00 | ELANE (0.65) | ELANESTAT3L3MBTL1MEN1MAPT | |
| SCHEMBL29425927 | 1.00 | ELANE (0.65) | ELANESTAT3L3MBTL1MEN1MAPT | |
| SCHEMBL29896779 | 1.00 | ELANE (0.65) | ELANESTAT3L3MBTL1MEN1MAPT | |
| SCHEMBL9057631 | 0.89 | ELANE (0.55) | ELANESTAT3L3MBTL1MEN1MAPT | |
| Scandoside SCHEMBL307654 | 0.88 | L3MBTL1 (0.61) | ELANESTAT3L3MBTL1MEN1MAPT | |
| Scandoside SCHEMBL29682452 | 0.88 | L3MBTL1 (0.61) | ELANESTAT3L3MBTL1MEN1MAPT | |
| Scandoside SCHEMBL29426072 | 0.88 | L3MBTL1 (0.61) | ELANESTAT3L3MBTL1MEN1MAPT | |
| SCHEMBL29425804 | 0.87 | STAT3 (0.56) | ELANESTAT3MEN1MAPTKMT2A | |
| SCHEMBL28912673 | 0.87 | ELANE (0.53) | ELANESTAT3MEN1MAPTKMT2A | |
| SCHEMBL29425847 | 0.87 | ELANE (0.53) | ELANESTAT3MEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4379068-B1 | IRIDOID OR SECO-IRIDOID DERIVATIVES AND THEIR USE IN A TANNING PROCESS | INSTITUT NAT DES SCIENCES APPLIQUEES DE ROUEN (FR) | 2025-06-04 | — | — | EP | claimed |
| EP-4379068-A1 | IRIDOID OR SECO-IRIDOID DERIVATIVES AND THEIR USE IN A TANNING PROCESS | Institut National Des Sciences Appliquées De Rouen (FR) | 2024-06-05 | — | — | EP | claimed |
| CN-109464514-A | A kind of capejasmine extract that treating hyperbileacidemia and its preparation and application | 中国中医科学院中药研究所 | 2019-03-15 | — | — | CN | claimed |
| CN-103242390-B | Method for extracting methyldeactylasperulosidate and Scandoside methyl ester | 鲁南制药集团股份有限公司 | 2017-02-15 | — | — | CN | claimed |
| CN-106093221-A | A kind of method of quality control of herbal mixture Yin Zhi Huang | 湖南师范大学 | 2016-11-09 | — | — | CN | claimed |
| US-12576097-B2 | Anti-tumor effective component of Hedyotis diffusa, preparation method therefor and use thereof | GUANGDONG NEW EAR LIFE TECHNOLOGY CO., LTD. (CN) | 2026-03-17 | — | — | US | disclosed |
| EP-4379068-B1 | IRIDOID OR SECO-IRIDOID DERIVATIVES AND THEIR USE IN A TANNING PROCESS | INSTITUT NAT DES SCIENCES APPLIQUEES DE ROUEN (FR) | 2025-06-04 | — | — | EP | disclosed |
| EP-3592432-B2 | GARDENIA EXTRACT USED FOR COLORING KERATIN FIBERS | FABRE PIERRE DERMO COSMETIQUE (FR) | 2024-07-17 | — | — | EP | disclosed |
| US-20220273687-A1 | ANTI-TUMOR EFFECTIVE COMPONENT OF HEDYOTIS DIFFUSA, PREPARATION METHOD THEREFOR AND USE THEREOF | GUANGDONG NEW EAR LIFE TECHNOLOGY CO., LTD. (CN) | 2022-09-01 | — | — | US | disclosed |
| EP-3409766-B1 | AN ESTERASE THAT IS CAPABLE OF CONVERTING IRIDOIDS AND SECO-IRIDOIDS | N ZYME BIOTEC GMBH (DE) | 2022-03-09 | — | — | EP | disclosed |
| US-11266593-B2 | Gardenia extract for dyeing keratin fibres | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2022-03-08 | — | — | US | disclosed |
| CN-109464514-A | A kind of capejasmine extract that treating hyperbileacidemia and its preparation and application | 中国中医科学院中药研究所 | 2019-03-15 | — | — | CN | disclosed |
| CN-103432024-A | Cosmetic composition with function of removing acne | INFINITUS CHINA CO LTD | 2013-12-11 | — | — | CN | disclosed |
| CN-103242390-A | Method for extracting methyldeactylasperulosidate and Scandoside methyl ester | LUNAN PHARM GROUP CORP | 2013-08-14 | — | — | CN | disclosed |
| CN-103242390-A | Method for extracting methyldeactylasperulosidate and Scandoside methyl ester | LUNAN PHARM GROUP CORP | 2013-08-14 | — | — | CN | disclosed |
| CN-102764324-A | Medicine composition for treating neoplastic diseases and improving immunity | ZHONGHE JIN | 2012-11-07 | — | — | CN | disclosed |
| CN-102764323-A | Method for preparing medicine composition for treating neoplastic diseases and improving immunity | ZHONGHE JIN | 2012-11-07 | — | — | CN | disclosed |
| CN-102727616-A | Ethyl acetate extract product of Chinese fevervine herb and root and application thereof | INST MEDICINAL PLANT DEV CAMS | 2012-10-17 | — | — | CN | disclosed |
| CN-1857483-A | Effective component of goldhair hedyotis herb and production process of its medicine composition | PINGSHAN PHARMACEUTICAL CO LTD (CN) | 2006-11-08 | — | — | CN | disclosed |
| CN-1107472-A | Use of cycloolefine ether terpenoid as yield increasing agent and root growth helping agent for crops | LUSHAN BOTAN GARDEN JIANGXI PR (CN) | 1995-08-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220273687-A1 | ANTI-TUMOR EFFECTIVE COMPONENT OF HEDYOTIS DIFFUSA, PREPARATION METHOD THEREFOR AND USE THEREOF | CYP51A1, DHPS, FDPS | ELANE 4378/4885STAT3 1327/4885L3MBTL1 3410/4885 |
| US-12576097-B2 | Anti-tumor effective component of Hedyotis diffusa, preparation method therefor and use thereof | HDGF, HCCS, PYGL | ELANE 4263/4885STAT3 1931/4885L3MBTL1 2145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.